Behind the Red Door

Behind the Red Door

Author: Karen B. Moore

Publisher:

Published: 2016

Total Pages: 0

ISBN-13: 9781599326603

DOWNLOAD EBOOK

Unlock Your Influence and Success Eye-catching, bold, and welcoming: a red door is all of these things. But is your organization reflective of such traits? Karen Moore, founder and CEO of Moore Communications Group, is redefining advocacy and can help you influence public policy, drive your business objectives, and foster engagement in your brand equity. In behind the RED DOOR, Karen Moore provides you with the knowledge and tools to: understand the value of advocacy engagement for your organization build your organization's advocacy plan mobilize advocates for success set advocacy goals and subsequently measure their success enhance your brand equity and viability through advocacy efforts Regardless of the goals within your organization, advocacy is the key to unlocking your success. So turn the first page. . . open the red door!


The Genius of American Corporate Law

The Genius of American Corporate Law

Author: Roberta Romano

Publisher: American Enterprise Institute

Published: 1993

Total Pages: 180

ISBN-13: 9780844738369

DOWNLOAD EBOOK

This is a study of the structure of American corporate law, which combines economic analysis with empirical insights to produce a number of policy insights. It is suitable for anyone studying corporate law, securities regulation, comparative company law or federalism.


Specificity, Function, and Development of NK Cells

Specificity, Function, and Development of NK Cells

Author: Klas Kärre

Publisher: Springer Science & Business Media

Published: 2012-12-06

Total Pages: 250

ISBN-13: 3642468594

DOWNLOAD EBOOK

Our understanding of the function of natural killer (NK) cells has dramatically changed in recent years. The discovery of NK receptors specific for MHC class I molecules, and the study of the role of co-stimulatory and adhesion molecules have led to an understanding of how NK cells recognize tumor and virally infected cells that have lost expression of MHC class I molecules or have altered distribution of normal cell surface molecules. Such recognition events lead to intracellular signals which can be either stimulatory or inhibitory. This book provides an insight into how NK cells develop, how they learn to distinguish altered cells from normal cells, and into their biological role in controlling infections and tumors.


Real World Drug Discovery

Real World Drug Discovery

Author: Robert M. Rydzewski

Publisher: Elsevier

Published: 2010-07-07

Total Pages: 535

ISBN-13: 0080914888

DOWNLOAD EBOOK

Drug discovery increasingly requires a common understanding by researchers of the many and diverse factors that go into the making of new medicines. The scientist entering the field will immediately face important issues for which his education may not have prepared him: project teams, patent law, consultants, target product profiles, industry trends, Gantt charts, target validation, pharmacokinetics, proteomics, phenotype assays, biomarkers, and many other unfamiliar topics for which a basic understanding must somehow be obtained. Even the more experienced scientist can find it frustratingly difficult to get an overview of the many factors involved in modern drug discovery and often only after years of exploring does a whole and integrated picture emerge in the mind of the researcher.Real World Drug Discovery: A Chemist's Guide to Biotech and Pharmaceutical Research presents this kind of map of the landscape of drug discovery. In a single, readable volume it outlines processes and explains essential concepts and terms for the recent science graduate wondering what to expect in pharma or biotech, the medicinal chemist seeking a broader and more timely understanding of the industry, or the contractor or collaborator whose understanding of the commercial drug discovery process could increase the value of his contribution to it. - Interviews with well-known experts in many of the fields involved, giving insightful comments from authorities on many of the sub-disciplines important to cutting edge drug discovery. - Helpful suggestions gleaned from years of experience in biotech and pharma, which represents a repository drug discovery "lore" not previously available in any book. - "Periodic Table of Drugs" listing current top-selling drugs arranged by target and laid out so that structural similarities and differences are plain and clear. - Extensive use of diagrams to illustrate concepts like biotech startup models, preteomic profiling for target identification, Gantt charts for project planning, etc.


Upper Tract Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Author: Shahrokh F. Shariat

Publisher: Springer

Published: 2014-09-13

Total Pages: 206

ISBN-13: 1493915010

DOWNLOAD EBOOK

Upper Tract Urothelial Carcinoma represents the first book of its kind to be dedicated solely to UTUC. It's aim is to improve understanding and eventually care of a disease that is greatly understudied and underappreciated, yet commonly dealt with by many medical and urologic oncologists. The volume features new data regarding genetic susceptibility, gene expression studies and causative factors; contemporary concepts and controversies regarding diagnosis and staging of UTUC; prediction tools and their value in treatment decisions within each disease stage and patient selection and treatment options such as endoscopic management, distal ureterectomy, radical nephroureterectomy and chemotherapy. Up-to-date information regarding boundaries of surgical resection, indication and extent of lymphadenectomy is covered as well as the role of perioperative/neoadjuvant chemotherapy in patients with high-risk UTUC. Upper Tract Urothelial Carcinoma will be of great value to all Urologists, Medical Oncologists and fellows in Urologic Oncology as well as upper level residents in training in Urology and Medical Oncology.


Compensating for Wetland Losses Under the Clean Water Act

Compensating for Wetland Losses Under the Clean Water Act

Author: National Research Council

Publisher: National Academies Press

Published: 2001-11-06

Total Pages: 348

ISBN-13: 0309133025

DOWNLOAD EBOOK

Recognizing the importance of wetland protection, the Bush administration in 1988 endorsed the goal of "no net loss" of wetlands. Specifically, it directed that filling of wetlands should be avoided, and minimized when it cannot be avoided. When filling is permitted, compensatory mitigation must be undertaken; that is, wetlands must be restored, created, enhanced, and, in exceptional cases, preserved, to replace the permitted loss of wetland area and function, such as water quality improvement within the watershed. After more than a dozen years, the national commitment to "no net loss" of wetlands has been evaluated. This new book explores the adequacy of science and technology for replacing wetland function and the effectiveness of the federal program of compensatory mitigation in accomplishing the nation's goal of clean water. It examines the regulatory framework for permitting wetland filling and requiring mitigation, compares the mitigation institutions that are in use, and addresses the problems that agencies face in ensuring sustainability of mitigated wetlands over the long term. Gleaning lessons from the mixed results of mitigation efforts to date, the book offers 10 practical guidelines for establishing and monitoring mitigated wetlands. It also recommends that federal, state, and local agencies undertake specific institutional reforms. This book will be important to anyone seeking a comprehensive understanding of the "no net loss" issue: policy makers, regulators, environmental scientists, educators, and wetland advocates.